Mirum Pharmaceuticals Inc (MIRM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -17,633 | -20,538 | -14,677 | -87,942 | -64,152 |
| Depreciation Amortization | 19,473 | 12,968 | 6,485 | 25,290 | 18,818 |
| Accounts receivable | -29,047 | -25,901 | -16,833 | -11,426 | -562 |
| Other Working Capital | -5,708 | -17,853 | -11,297 | 22,591 | 24,273 |
| Other Operating Activity | 82,675 | 61,403 | 34,361 | 61,812 | 37,016 |
| Operating Cash Flow | $49,760 | $10,079 | $-1,961 | $10,325 | $15,393 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -24,606 | -22,566 | -16,093 | -69,132 | -69,793 |
| PPE Investments | -354 | -167 | -41 | -993 | -973 |
| Purchase Sale Intangibles | N/A | N/A | N/A | -20,000 | -20,000 |
| Other Investing Activity | 0 | 0 | 0 | -20,000 | -20,000 |
| Investing Cash Flow | $-24,960 | $-22,733 | $-16,134 | $-90,125 | $-90,766 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 31,143 | 15,047 | 6,359 | 17,699 | 12,359 |
| Financing Cash Flow | $31,143 | $15,047 | $6,359 | $17,699 | $12,359 |
| Exchange Rate Effect | 3,630 | 3,281 | 1,055 | -1,297 | 82 |
| Beginning Cash Position | 222,928 | 222,928 | 222,928 | 286,326 | 286,326 |
| End Cash Position | 282,501 | 228,602 | 212,247 | 222,928 | 223,394 |
| Net Cash Flow | $59,573 | $5,674 | $-10,681 | $-63,398 | $-62,932 |
| Free Cash Flow | |||||
| Operating Cash Flow | 49,760 | 10,079 | -1,961 | 10,325 | 15,393 |
| Capital Expenditure | -354 | -167 | -41 | -993 | -973 |
| Free Cash Flow | 49,406 | 9,912 | -2,002 | 9,332 | 14,420 |